Compare PLSE & WRBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PLSE | WRBY |
|---|---|---|
| Founded | 2014 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Ophthalmic Goods |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.6B | 3.1B |
| IPO Year | 2015 | 2021 |
| Metric | PLSE | WRBY |
|---|---|---|
| Price | $53.80 | $25.89 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 14 |
| Target Price | ★ $60.67 | $30.46 |
| AVG Volume (30 Days) | 401.8K | ★ 3.1M |
| Earning Date | 11-05-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 105.88 |
| EPS | N/A | ★ 0.06 |
| Revenue | N/A | ★ $871,905,000.00 |
| Revenue This Year | $480.71 | $11.38 |
| Revenue Next Year | $177.98 | $17.05 |
| P/E Ratio | ★ N/A | $428.00 |
| Revenue Growth | N/A | ★ 13.04 |
| 52 Week Low | $12.56 | $14.96 |
| 52 Week High | $58.90 | $31.00 |
| Indicator | PLSE | WRBY |
|---|---|---|
| Relative Strength Index (RSI) | 58.83 | 52.69 |
| Support Level | $49.01 | $23.33 |
| Resistance Level | $55.36 | $27.35 |
| Average True Range (ATR) | 3.43 | 1.29 |
| MACD | 0.37 | 0.01 |
| Stochastic Oscillator | 88.36 | 70.77 |
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed Field Ablation (nsPFA) technology delivers nanosecond pulses of electrical energy to nonthermally clear cells while sparing adjacent noncellular tissue.
Warby Parker Inc is a mission-driven, lifestyle brand that operates at the intersection of design, technology, healthcare, and social enterprise. The Company provides holistic vision care by offering eyewear, contacts, and eye care directly to consumers through its integrated, omnichannel platform. The company predominantly derives revenue from the sales of eyewear products, optical services, and accessories. The firm sells products and services through its stores, website, and mobile apps. Revenue generated from eyewear products includes the sales of prescription and non-prescription optical glasses and sunglasses, contact lenses, eyewear accessories, and expedited shipping charges.